Sentence examples for biomarkers that are capable from inspiring English sources

Using multivariate statistical analysis tools, we could identify non-invasive metabolite biomarkers that are capable to discriminate between various stages of fibrosis, necroinflammation and steatosis.

Therefore, there is a critical need for improved molecular biomarkers that are capable of detecting early stage disease, indicating recurrence of disease, as well as predicting the progression of benign high-risk lesions and intraductal carcinoma in situ to invasive carcinoma.

This entails the development of predictive biomarkers that are capable of predicting response or outcome [ 100– 102].

The neural substrates of cognitive impairment in Parkinson's disease remain only partially understood and underscore the need to establish imaging biomarkers that are capable of aiding the identification of 'at risk' patients for dementia and by so doing help in their early diagnosis and treatment.

Diagnostics that are capable of detecting multiple biomarkers are improving the accuracy and efficiency of bioassays.

Growth in translational research, focused on the identification and validation of disease biomarkers, has led to the development of biorepositories that are capable of providing high quality biospecimens with detailed clinical annotations.

It has thus become important to acquire more information on biomarkers present in primary lesions or in their margins that are capable of predicting disease evolution in order to plan the most effective and least expensive personalized therapy.

However, there remains a significant portion of both black and white individuals that are resistant to HCTZ therapy, and, presently, no biomarkers exist that are capable of identifying which of these patients will experience adverse outcomes or which patients will be resistant to treatment.

Measurements were also taken of biomarkers that are used to predict a person's risk of stroke and heart attack.

Their Proof-of-Concept work in Huntington's Disease validated eight biomarkers that are 100percentt accurate for classifying early versus late-stage disease, and disease progression.

Everything that's capable of exploding explodes.